Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

10.30
Delayed Data
As of Jan 17
 +0.04 / +0.39%
Today’s Change
8.70
Today|||52-Week Range
24.37
+11.96%
Year-to-Date
Here's Why Insys Therapeutics Plummeted 67.2% in 2016
Jan 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close10.26
Today’s open10.55
Day’s range10.15 - 10.60
Volume768,165
Average volume (3 months)844,361
Market cap$736.4M
Dividend yield--
Data as of 01/17/2017

Growth & Valuation

Earnings growth (last year)+48.08%
Earnings growth (this year)-75.00%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+48.92%
P/E ratio33.2
Price/Sales6.55
Price/Book2.91

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...-0.61-2.13%
ACIUAC Immune Ltd-0.30-2.22%
LCILannett Company Inc-0.75-3.69%
MGNXMacroGenics Inc-0.87-4.30%
Data as of 01/17/2017

Financials

Next reporting dateMarch 7, 2017
EPS forecast (this quarter)$0.02
Annual revenue (last year)$330.8M
Annual profit (last year)$58.5M
Net profit margin17.68%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive &
Medical Officer
Santosh J. Vetticaden
Chief Financial &
Accounting Officer
Darryl S. Baker
Corporate headquarters
Chandler, Arizona

Forecasts


Search for Jobs